CovidResearchTrials by Shray Alag

CovidResearchTrials Covid 19 Research using Clinical Trials (Home Page)

Standard of Care (SOC) and Colchicine+RosuvastatinWiki

Developed by Shray Alag
Clinical Trial MeSH HPO Drug Gene SNP Protein Mutation


Correlated Drug Terms (1)

Name (Synonyms) Correlation
drug1775 Patient-Reported Online Questionnaire on Olfactory & Taste Disturbances Wiki 0.71

Correlated MeSH Terms (5)

Name (Synonyms) Correlation
D004408 Dysgeusia NIH 0.58
D000857 Olfaction Disorders NIH 0.29
D007239 Infection NIH 0.06
D045169 Severe Acute Respiratory Syndrome NIH 0.05
D018352 Coronavirus Infections NIH 0.04

Correlated HPO Terms (1)

Name (Synonyms) Correlation
HP:0000458 Anosmia HPO 0.29

There is one clinical trial.

Clinical Trials

1 Colchicine/Statins for the Prevention of COVID-19 Complications (COLSTAT) Trial

This is a pragmatic randomized open-label study of the safety and efficacy of the combination of colchicine and Rosuvastatin in addition to standard of care (SOC) compared to SOC alone in hospitalized patients with SARS-CoV-2

NCT04472611 SARS-CoV-2 Drug: Standard of Care (SOC) and Colchicine+Rosuvastatin

Primary Outcomes

Description: As defined by World Health Organization Ordinal Scale, which ranges from 1 to 8. Severity of COVID measured by WHO Scores 5-8: Defined as 5= Hospitalized requiring including CPAP, face mask, high flow nasal cannula (Excludes regular nasal cannula) 6= Hospitalized requiring intubation and mechanical ventilation 7= Hospitalized requiring mechanical ventilation and additional organ support (vasopressors, renal replacement therapy, ECMO) 8= Death

Measure: COVID 19 Severity

Time: 30 Days

No related HPO nodes (Using clinical trials)